The Department of Justice’s Antitrust Division today announced a settlement that would allow CVS Health and Aetna to proceed with their proposed merger if Aetna divests its Medicare Part D prescription drug plans to WellCare. The settlement was filed in federal court as part of a civil antitrust lawsuit brought by the department and state attorneys general from California, Florida, Hawaii, Mississippi and Washington over competitive concerns with the merger. If approved by the court, the settlement would resolve those concerns, the agency said.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services Jan. 26 released proposed changes to Medicare Advantage plan capitation rates and Part D payment policies for…
Headline
The AHA Jan. 26 expressed support and provided its perspective on certain provisions within the Centers for Medicare & Medicaid Services’ proposed…
Headline
The AHA Jan. 20 made recommendations to Congress on modernizing the Medicare Access and CHIP Reauthorization Act. Among the proposals, the AHA recommended…
Headline
The comment period for the Centers for Medicare & Medicaid Services' proposed rule for policies governing the Medicare Advantage and Part D programs for…
Headline
The Medicare Payment Advisory Commission Jan. 15 voted to recommend that Congress update Medicare payment rates for hospital inpatient and outpatient services…
Headline
UnitedHealth Group announced Jan. 14 that it launched a six-month pilot program to reduce Medicare Advantage payment processing times by half for rural…